Risk of thromboembolic events in patients with atrial flutter

American Journal of Cardiology

Volumn 82, Issue 5, 1998, Pages 580-583

  Seidl, Karlheinz ^a,b   Hauer, Bernd ^a   Schwick, Nicola G ^a   Zellner, Dietmar ^a   Zahn, Ralf ^a   Senges, Jochen ^a  

^a Cardioloqy ^*  (Germany)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; CATHETER ABLATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; ATRIAL FLUTTER; CATHETER ABLATION; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; MIDDLE AGED; ODDS RATIO; RECURRENCE; RISK; THROMBOEMBOLISM;

EID: 0031702820     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00419-6     Document Type: Article

References (19)

1. Wolf PA, Dawber TR, Thomas HE, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study. Neurol 1978;28:973-977.
2. Petersen P, Boysen G, Godtfredsen J, Anderson ED, Andersen B. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thrombo-embolic complications in chronic atrial fibrillation: the Copenhagen AFA-SAK study. Lancet 1989;1:175-179.
3. Stroke Prevention in Atrial Fibrillation Study Group Investigators. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med 1990;322:863-868.
4. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511.
5. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Int Med 1994;154:1449-1457.
6. Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotic therapy in atrial fibrillation. Chest 1992;102:426S-433S.
7. Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 1992;19:851-855.
8. Wood KA, Eisenberg, SJ, Kalman JM, Drew BJ, Saxon LA, Lee RJ, Lesh MD, Scheinman MM. Risk of thromboembolism in chronic atrial flutter. Am J Cardiol 1997;79:1043-1047.
9. Grimm RA, Stewart WJ, Arheart KL, Thomas JD, Klein AL. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events. J Am Coll Cardiol 1997;29:582-589.
10. Irani WN, Grayburn PA, Afridi I. Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter: a prospective study using transesophageal echocardiography. Circulation 1997;95:962-966.
11. Morley J, Marinchak R, Rials SJ, Kowey P. Atrial fibrillation, anticoagulation and stroke. Am J Cardiol 1996;77:38A-44A.
12. Bikkina M, Alpert MA, Mulekar M, Shakoor A, Massey CV, Covin FA. Prevalence of intraatrial thrombus in patients with atrial flutter. Am J Cardiol 1995;76:186-189.
13. Santiago D, Warshofsky M, Li-Mandri G, Di-Tullio M, Coromilas J, Reiffel J, Homma-S. Left atrial appendage function and thrombus formation in atrial fribrillation-flutter: a transesophageal echocardiographic study. J Am Coll Cardiol 1994;24:159-164.
14. Black IW, Hopkins AP, Lee LCL, Walsh WF. Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. Am Heart J 1993;126:375-381.
15. Pagadala P, Gummadi SS, Olshansky B. Thromboembolic risk of chronic atrial flutter:is the risk underestimated? (abstr). Circulation 1994;90 (suppl I):I-398.
16. Lanzarotti C, Olshansky B. Thromboembolic risk of chronic atrial flutter: is the risk underestimated? J Am Coll Cardiol 1997;30:1506-1511.
17. Feltes TF, Friedman RA. Transesophageal echo cardiographic detection of atrial thrombi in patients with nonfibrillation atrial tachyarrhythmias and congenital heart disease. J Am Coll Cardiol 1994;24:1365-1370.
18. Moreya E, Finkelhor RS, Cebul RD. Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials. Am Heart J 1995;129:71-75.
19. Orr J. Embolism in auricular flutter. Br Med J 1921;2:576-579.